These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 10083506

  • 1. Mycophenolate mofetil in living donor renal allograft recipients.
    Park K, Moon JI, Kim SI, Kim YS.
    Transplant Proc; 1999; 31(1-2):1133. PubMed ID: 10083506
    [No Abstract] [Full Text] [Related]

  • 2. Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients.
    Park K, Kim SI, Moon JI, Kim YS, Kim MS.
    Transplant Proc; 1998 Nov; 30(7):3575. PubMed ID: 9838565
    [No Abstract] [Full Text] [Related]

  • 3. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
    Remport A, Sasvári I, Toronyi E, Borka P, Lázár N, Járay J, Perner F.
    Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
    [No Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
    Carl S, Wiesel M.
    Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of two corticosteroid regimens in combination with CellCept and cyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study. M 55002 Study Group.
    Lebranchu Y.
    Transplant Proc; 1999 Nov; 31(1-2):249-50. PubMed ID: 10083095
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
    Kupin W, Venkat KK, Goggins M, Douzdjian V, Escobar F, Mozes M, Abouljoud M.
    Transplant Proc; 1999 Nov; 31(1-2):1131-2. PubMed ID: 10083505
    [No Abstract] [Full Text] [Related]

  • 8. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
    Rudich SM, Bhaduri S, Chang T, Cahn J, Katznelson S, Perez RV.
    Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
    [No Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil/Neoral/steroid vs Neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients.
    Carmellini M, Vistoli F, Bellini R, Boggi U, Rindi P, Rizzo G, Mosca F.
    Transplant Proc; 1999 Apr 27; 31(1-2):1162-4. PubMed ID: 10083519
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with mycophenolate mofetil in kidney transplant patients with organs from donors aged over 60 years: one-year monitoring results.
    Agraz I, Guirado L, Andrade M, Olaya M, Vila A, Solá R.
    Transplant Proc; 1999 Sep 27; 31(6):2272-4. PubMed ID: 10500573
    [No Abstract] [Full Text] [Related]

  • 12. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection.
    Behrend M, Lueck R, Pichlmayr R.
    Transplant Proc; 1997 Nov 27; 29(7):2927-9. PubMed ID: 9365617
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J.
    Transplant Proc; 1999 Nov 27; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract] [Full Text] [Related]

  • 14. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
    Cubas A, Herrero JC, Morales E, Carreño A, Dominguez-Gil B, Cirujeda A, Praga M, Ortuño T, Hernandez E, Delgado M, Andres A, Morales JM.
    Transplant Proc; 1999 Sep 27; 31(6):2265-6. PubMed ID: 10500570
    [No Abstract] [Full Text] [Related]

  • 15. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM, Andrés A, Morales E, Herrero JC, Cubas A, Praga M, Hernández E, Ortuño T, Dominguez-Gil B, Carreño A, Delgado M, Manzanares C.
    Transplant Proc; 1999 Nov 27; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B.
    Transplant Proc; 1997 Nov 27; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D, Madras PN, Conway P, Davis C, Simpson MA, Monaco AP.
    Transplant Proc; 1997 Nov 27; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract] [Full Text] [Related]

  • 18. Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine.
    Kupin W, Venkat KK, Goggins M, Douzdjian V, Escobar F, Mozes M, Abouljoud M.
    Transplant Proc; 1999 Nov 27; 31(1-2):744-5. PubMed ID: 10083317
    [No Abstract] [Full Text] [Related]

  • 19. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF, Górriz JL, Sancho A, Avila A, Alcoy E, Pallardó LM.
    Transplant Proc; 1999 Sep 27; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.